Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2006 by Maisonneuve-Rosemont Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Hippocrate Research & Development
Information provided by:
Maisonneuve-Rosemont Hospital
ClinicalTrials.gov Identifier:
NCT00290485
First received: February 9, 2006
Last updated: April 6, 2006
Last verified: April 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given